Home Australia The Omicron COVID-19 variant has sparked travel bans, but they aren’t the answer to stopping it #englishheadline #Omicron #COVID19 #variant #sparked #travel #bans #arent #answer #stopping

The Omicron COVID-19 variant has sparked travel bans, but they aren’t the answer to stopping it #englishheadline #Omicron #COVID19 #variant #sparked #travel #bans #arent #answer #stopping

by englishheadline
0 comment

Australia has followed other countries and regions – including the United States, Canada, United Kingdom and the European Union – and banned travellers from nine southern African countries.

Read More

Image for read more article 'What you need to know about Omicron, the new COVID-19 'variant of concern''

Australians seeking to return home from southern Africa will still be able to do so. But they will enter hotel quarantine and be tested. Those who have returned from the nine countries – South Africa, Namibia, Zimbabwe, Botswana, Lesotho, Eswatini, the Seychelles, Malawi and Mozambique – in the past 14 days will have to isolate.

But Omicron has already been detected in other regions, including the United Kingdom, Germany, Israel, Hong Kong and Belgium. So while a travel ban on southern African countries may slow the spread and buy limited time, it’s unlikely to stop it.

As the Australian government and others act to protect their own citizens, this should be accompanied by additional resources to support countries in southern Africa and elsewhere that take prompt action.

When was Omicron detected?

The variant was identified on 22 November in South Africa, from a sample collected from a patient on November 9.

South African virologists took prompt action, conferred with colleagues through the Network of Genomic Surveillance in South Africa, liaised with government and notified the World Health Organization on 24 November.

This is in keeping with the International Health Regulations that guide how countries should respond.

The behaviour of this new variant is still unclear. Some have claimed the rate of growth of Omicron infections, which reflects its transmissibility, may be even higher than those of the Delta variant. This “growth advantage” is yet to be proven but is concerning.

A petrol attendant uses next to a newspaper headline in Pretoria, South Africa, on Saturday, 27 November.

Source: AP/AAP

“Kneejerk” response vs WHO recommendations

African scientists and politicians have been disappointed in what they see as a “kneejerk” response from countries imposing travel bans. They argue the bans will have significant negative effects for the South African economy, which traditionally welcomes global tourists over the summer year-end period.

They note it is still unclear whether the new variant originated in South Africa, even if it was first identified there. As Omicron has already been detected in several other countries, it may already be circulating in regions not included in the travel bans.

Travel bans on countries detecting new variants, and the subsequent economic costs, may also act as a disincentive for countries to reveal variants of concern in future.

The WHO does not generally recommend flight bans or other forms of travel embargoes. Instead, it argues interventions of proven value should be prioritised: vaccination, hand hygiene, physical distancing, well-fitted masks, and good ventilation.

In response to variants of concern, the WHO calls on all countries to enhance surveillance and sequencing, report initial cases or clusters and undertake investigations to improve understanding of the variant’s behaviour.

Omicron must be taken seriously. Its features are worrying, but there are large gaps in our current knowledge. While further analyses are undertaken, the variant should be controlled with testing, tracing, isolation, applying known public health measures, and ongoing surveillance.

What can wealthier countries do to help?

Wealthy countries such as Australia should support African nations and others to share early alerts of potentially serious communicable disease threats, and help mitigate these threats.

As the Independent Panel for Pandemic Preparedness and Response noted in May: “public health actors only see downsides from drawing attention to an outbreak that has the potential to spread.”

A healthcare worker administers the Pfizer COVID-19 vaccine to a woman in Katlehong, east of Johannesburg, South Africa.

Source: AP/AAP

The panel recommended creating incentives to reward early response action. This could include support to:

  • establish research and educational partnerships
  • strengthen health systems and communicable disease surveillance
  • greatly improve vaccine availability, distribution, and equity
  • consider financial compensation, through some form of solidarity fund against pandemic risk

Boosting vaccine coverage is key

Vaccines remain the mainstay of protection against the most severe effects of COVID-19.

It’s unclear how effective vaccines will be against Omicron, but some degree of protection is presumed likely. Pfizer has also indicated it could develop an effective vaccine against a new variant such as Omicron within 100 days or so.

COVID’s persistence is partly attributable to patchy immunisation coverage across many parts of the world, notably those least developed. South Africa itself is better off than most countries on the continent, yet only 24 per cent of the adult population are currently fully vaccinated. For the whole of Africa, this drops to only 7.2 per cent.

Greater global support is urgently needed to boost these vaccination rates.

Read More

Image for read more article 'Government asks ATAGI to review COVID-19 vaccine booster time frame in response to Omicron variant'

African institutions and leaders, supported by global health and vaccine experts, have argued for mRNA vaccine manufacturing facilities on the African continent. These would prioritise regional populations, overcome supply-chain problems, and respond in real time to emerging disease threats.

Yet developing nations face significant barriers to obtaining intellectual property around COVID-19 vaccine development and production.

While there is still much to learn about the behaviour and impact of Omicron, the global community must demonstrate and commit real support to countries that do the right thing by promptly and transparently sharing information.

Anthony Zwi is a professor of global health and development at UNSW. 

Anthony Zwi does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.


#Omicron #COVID19 #variant #sparked #travel #bans #arent #answer #stopping

You may also like

Leave a Comment